Advertisement

Journal of Neurology

, Volume 255, Issue 1, pp 49–55 | Cite as

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

  • C. SmestadEmail author
  • L. Sandvik
  • T. Holmoy
  • H. F. Harbo
  • E. G. Celius
ORIGINAL COMMUNICATION

Abstract

Objectives

Oslo, the capital of Norway, has a high prevalence of multiple sclerosis (MS). In recent decades there has been substantial immigration to Oslo from Asia, the Middle East and Africa. The aim of the study was to estimate the prevalence of MS among non-Western immigrants living in Oslo, adjusted for duration of residence.

Methods

Data were obtained from the MS registry at Ullevål University Hospital. The prevalence of MS was adjusted for ethnicity, age and duration of residence in Norway.

Results

A total of 786 definite MS patients were alive and resident in Oslo on 31 December 2005, yielding a crude prevalence of 148/105. Twentyseven patients were of non-Western origin: Middle East 14, Asia 9, Africa 4. The non-Western patients' mean age at migration was 20. The crude prevalence (95 % CI) of MS patients was 170/105 (159–182) for the Norwegian/Western, 85/105 (50–143) for the Middle East, 21/105 (11–41) for the Asian, and 20/105 (7–53) for the African cohorts. The high MS prevalence in the Middle East cohort and the low prevalence among Asian/African immigrants were also pronounced after adjustment for age and duration of residence.

Conclusions

The Middle East immigrants had a markedly higher prevalence of MS despite a shorter duration of residence than other non-Western patients. These findings suggest that people from the Middle East have a greater genetic disposition for MS. Furthermore, the high age at migration among the non-Western immigrants indicates that possible environmental factors affecting MS risk may also act on adults.

Key words

multiple sclerosis prevalence ethnicity migration Norway 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    (2005) McAlpine's multiple sclerosis. Churchill Livingstone Elsevier, PhiladelphiaGoogle Scholar
  2. 2.
    Al-Araji A, Mohammed AI (2005) Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 234:67–71PubMedCrossRefGoogle Scholar
  3. 3.
    al-Din AS, El-Khateeb M, Kurdi A, Mubaidin A, Wriekat A, al-Shehab A, Khalil RW (1995) Multiple sclerosis in Arabs in Jordan. J Neurol Sci 131:144–149PubMedCrossRefGoogle Scholar
  4. 4.
    al-Din AS, Khogali M, Poser CM, al- Nassar KE, Shakir R, Hussain J, Behbahani K, Chadha G (1990) Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J Neurol Sci 100:137–141PubMedCrossRefGoogle Scholar
  5. 5.
    Alshubaili AF, Alramzy K, Ayyad YM, Gerish Y (2005) Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol 53:125–131PubMedCrossRefGoogle Scholar
  6. 6.
    Alstadhaug KB, Olavsen J, Salvesen R (2005) [Occurrence of multiple sclerosis in Nordland, 1970–1999]. Tidsskr Nor Laegeforen 125:431–433PubMedGoogle Scholar
  7. 7.
    Alter M, Kahana E, Zilber N, Miller A (2006) Multiple sclerosis frequency in Israel's diverse populations. Neurology 66:1061–1066PubMedCrossRefGoogle Scholar
  8. 8.
    Alter M, Leibowitz U, Speer J (1966) Risk of multiple sclerosis related to age at immigration to Israel. Arch Neurol 15:234–237PubMedGoogle Scholar
  9. 9.
    Amirzargar A, Mytilineos J, Farjadian S, Doroudchi M, Scherer S, Opelz G, Ghaderi A (2001) Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 62:1234–1238PubMedCrossRefGoogle Scholar
  10. 10.
    Cabre P, Signate A, Olindo S, Merle H, Caparros-Lefebvre D, Bera O, Smadja D (2005) Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 128:2899–2910PubMedCrossRefGoogle Scholar
  11. 11.
    Celius EG, Vandvik B (2001) Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 8:463–469PubMedCrossRefGoogle Scholar
  12. 12.
    Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R (2004) Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. Acta Neurol Scand 109:378–384PubMedCrossRefGoogle Scholar
  13. 13.
    Dean G (1967) Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. Br Med J 2:724–730PubMedGoogle Scholar
  14. 14.
    Dean G, Elian M (1997) Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 63:565–568PubMedGoogle Scholar
  15. 15.
    Dean G, Kurtzke JF (1971) On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J 3:725–729PubMedCrossRefGoogle Scholar
  16. 16.
    Dean G, McLoughlin H, Brady R, Adelstein AM, Tallett-Williams J (1976) Multiple sclerosis among immigrants in Greater London. Br Med J 1:861–864PubMedGoogle Scholar
  17. 17.
    Detels R, Visscher BR, Haile RW, Malmgren RM, Dudley JP, Coulson AH (1978) Multiple sclerosis and age at migration. Am J Epidemiol 108: 386–393PubMedGoogle Scholar
  18. 18.
    El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y (2006) Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 253(9):1210–1216PubMedCrossRefGoogle Scholar
  19. 19.
    Elian M, Nightingale S, Dean G (1990) Multiple sclerosis among United Kingdom- born children of immigrants from the Indian subcontinent, Africa and the West Indies. [see comment]. J Neurol Neurosurg Psychiatry 53:906–911PubMedGoogle Scholar
  20. 20.
    Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F (2006) Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 27:39–44PubMedCrossRefGoogle Scholar
  21. 21.
    Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47:425–448PubMedCrossRefGoogle Scholar
  22. 22.
    Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM (2006) A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 66:182–186PubMedCrossRefGoogle Scholar
  23. 23.
    Hammond SR, English DR, McLeod JG (2000) The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 123 (Pt 5):968–974PubMedCrossRefGoogle Scholar
  24. 24.
    Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sorensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A (2004) Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63:237–247PubMedCrossRefGoogle Scholar
  25. 25.
    Hillert J (1994) Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 36 (Suppl):S15-S17PubMedCrossRefGoogle Scholar
  26. 26.
    Kahana E, Zilber N, Abramson JH, Biton V, Leibowitz Y, Abramsky O (1994) Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated. J Neurol 241:341–346PubMedCrossRefGoogle Scholar
  27. 27.
    Kalanie H, Kamgooyan M, Sadeghian H, Kalanie AR (2000) Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran. Mult Scler 6:317–319PubMedGoogle Scholar
  28. 28.
    Kankonkar S, Jeyanti G, Singhal BS, Shankarkumar U (2003) Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India. Hum Immunol 64:478–482PubMedCrossRefGoogle Scholar
  29. 29.
    Karni A, Kahana E, Zilber N, Abramsky O, Alter M, Karussis D (2003) The frequency of multiple sclerosis in Jewish and Arab populations in greater Jerusalem. Neuroepidemiology 22:82–86PubMedCrossRefGoogle Scholar
  30. 30.
    Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2:117–127PubMedCrossRefGoogle Scholar
  31. 31.
    Kleinbaum DG (1982) Epidemiologic research: principles and quantitative methods.Van Nostrand Reinhold, New YorkGoogle Scholar
  32. 32.
    Kurtzke JF, Delasnerie-Laupretre N, Wallin MT (1998) Multiple sclerosis in North African migrants to France. Acta Neurologica Scandinavica 98:302–309PubMedCrossRefGoogle Scholar
  33. 33.
    Lofthus E (1998) Immigrants in Norway: a summary of findings. Statistisk sentralbyrå, OsloGoogle Scholar
  34. 34.
    Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3:709–718PubMedCrossRefGoogle Scholar
  35. 35.
    Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 74:160–167PubMedCrossRefGoogle Scholar
  36. 36.
    Poser CM, Paty DW, Scheinberg L, Mc- Donald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231PubMedCrossRefGoogle Scholar
  37. 37.
    Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117–139PubMedCrossRefGoogle Scholar
  38. 38.
    Saida T (2004) First Regional MS Forum Meeting raises MS awareness and highlights questions. The MS Forum Pan-Asian Conference, 912 October 2003, Bangkok, Thailand. Int MS J 11:32–33PubMedGoogle Scholar
  39. 39.
    The Municipality of Oslo.Development and improvement authority. (2005) [Statistical Yearbook of Oslo 2005 (online)]. The Municipality of Oslo.Development and improvement authority, OsloGoogle Scholar
  40. 40.
    Wadia NH, Bhatia K (1990) Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India. Ann Neurol 28:177–179PubMedCrossRefGoogle Scholar
  41. 41.
    Wasay M, Khatri IA, Khealani B, Sheerani M (2006) MS in Asian countries. Int MS J 13:58–65PubMedGoogle Scholar
  42. 42.
    Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  • C. Smestad
    • 1
    Email author
  • L. Sandvik
    • 2
  • T. Holmoy
    • 1
    • 3
  • H. F. Harbo
    • 1
    • 3
  • E. G. Celius
    • 1
  1. 1.Dept. of NeurologyUllevål University HospitalOsloNorway
  2. 2.Center for Clinical ResearchUllevål University HospitalOsloNorway
  3. 3.Institute of Immunology, Faculty Division RikshospitaletUniversity of OsloNorway

Personalised recommendations